Global Age Related Macular Degeneration Drug Industry Market Analysis & Forecast 2018-2023

July 2018 | 90 pages | ID: GE1C9F977C6EN
S&P Consulting

Abstracts

In the Global Age Related Macular Degeneration Drug Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is forecasted to reach XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023.

It covers Regional Segment Analysis, Type, Appliction, Major Manufactures, Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.

Global Age Related Macular Degeneration Drug Market: Regional Segment Analysis
North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:
Applied Genetic Technologies Corp
Astellas Pharma Inc
Benitec Biopharma Ltd
Biokine Therapeutics Ltd
Crinetics Pharmaceuticals Inc
Critical Pharmaceuticals Ltd
Daiichi Sankyo Company Ltd
Diffusion Pharmaceuticals Inc
Dong-A Socio Holdings Co Ltd

Global Age Related Macular Degeneration Drug Market: Product Segment Analysis
Lucentis
Eylea
Other

Global Age Related Macular Degeneration Drug Market: Application Segment Analysis
Clinic
Hospital
Others

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

Global Age Related Macular Degeneration Drug Industry Market Analysis & Forecast 2018-2023

CHAPTER 1 AGE RELATED MACULAR DEGENERATION DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Age Related Macular Degeneration Drug
1.2 Age Related Macular Degeneration Drug Market Segmentation by Type in 2016
  1.2.1 Global Production Market Share of Age Related Macular Degeneration Drug by Type in 2016
  1.2.1 Lucentis
  1.2.2 Eylea
  1.2.3 Other
1.3 Age Related Macular Degeneration Drug Market Segmentation by Application in 2016
  1.3.1 Age Related Macular Degeneration Drug Consumption Market Share by Application in 2016
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 Age Related Macular Degeneration Drug Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Age Related Macular Degeneration Drug (2013-2023)
  1.5.1 Global Product Sales and Growth Rate (2013-2023)
  1.5.2 Global Product Revenue and Growth Rate (2013-2023)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON AGE RELATED MACULAR DEGENERATION DRUG INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG MARKET COMPETITION BY MANUFACTURERS

3.1 Global Age Related Macular Degeneration Drug Production and Share by Manufacturers (2016 and 2017)
3.2 Global Age Related Macular Degeneration Drug Revenue and Share by Manufacturers (2016 and 2017)
3.3 Global Age Related Macular Degeneration Drug Average Price by Manufacturers (2016 and 2017)
3.4 Manufacturers Age Related Macular Degeneration Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Age Related Macular Degeneration Drug Market Competitive Situation and Trends
  3.5.1 Age Related Macular Degeneration Drug Market Concentration Rate
  3.5.2 Age Related Macular Degeneration Drug Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG PRODUCTION, REVENUE (VALUE) BY REGION (2013-2018)

4.1 Global Age Related Macular Degeneration Drug Production by Region (2013-2018)
4.2 Global Age Related Macular Degeneration Drug Production Market Share by Region (2013-2018)
4.3 Global Age Related Macular Degeneration Drug Revenue (Value) and Market Share by Region (2013-2018)
4.4 Global Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
4.5 North America Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
  4.5.1 North America Age Related Macular Degeneration Drug Production and Market Share by Manufacturers
  4.5.2 North America Age Related Macular Degeneration Drug Production and Market Share by Type
  4.5.3 North America Age Related Macular Degeneration Drug Production and Market Share by Application
4.6 Europe Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
  4.6.1 Europe Age Related Macular Degeneration Drug Production and Market Share by Manufacturers
  4.6.2 Europe Age Related Macular Degeneration Drug Production and Market Share by Type
  4.6.3 Europe Age Related Macular Degeneration Drug Production and Market Share by Application
4.7 China Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
  4.7.1 China Age Related Macular Degeneration Drug Production and Market Share by Manufacturers
  4.7.2 China Age Related Macular Degeneration Drug Production and Market Share by Type
  4.7.3 China Age Related Macular Degeneration Drug Production and Market Share by Application
4.8 Japan Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
  4.8.1 Japan Age Related Macular Degeneration Drug Production and Market Share by Manufacturers
  4.8.2 Japan Age Related Macular Degeneration Drug Production and Market Share by Type
  4.8.3 Japan Age Related Macular Degeneration Drug Production and Market Share by Application
4.9 Southeast Asia Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
  4.9.1 Southeast Asia Age Related Macular Degeneration Drug Production and Market Share by Manufacturers
  4.9.2 Southeast Asia Age Related Macular Degeneration Drug Production and Market Share by Type
  4.9.3 Southeast Asia Age Related Macular Degeneration Drug Production and Market Share by Application
4.10 India Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
  4.10.1 India Age Related Macular Degeneration Drug Production and Market Share by Manufacturers
  4.10.2 India Age Related Macular Degeneration Drug Production and Market Share by Type
  4.10.3 India Age Related Macular Degeneration Drug Production and Market Share by Application

CHAPTER 5 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2013-2018)

5.1 Global Age Related Macular Degeneration Drug Consumption by Regions (2013-2018)
5.2 North America Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2013-2018)
5.3 Europe Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2013-2018)
5.4 China Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2013-2018)
5.5 Japan Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2013-2018)
5.6 Southeast Asia Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2013-2018)
5.7 India Age Related Macular Degeneration Drug Production, Consumption, Export, Import by Regions (2013-2018)

CHAPTER 6 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Age Related Macular Degeneration Drug Production and Market Share by Type (2013-2018)
6.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Type (2013-2018)
6.3 Global Age Related Macular Degeneration Drug Price by Type (2013-2018)
6.4 Global Age Related Macular Degeneration Drug Production Growth by Type (2013-2018)

CHAPTER 7 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG MARKET ANALYSIS BY APPLICATION

7.1 Global Age Related Macular Degeneration Drug Consumption and Market Share by Application (2013-2018)
7.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Type (2013-2018)
7.3 Global Age Related Macular Degeneration Drug Consumption Growth Rate by Application (2013-2018)
7.4 Market Drivers and Opportunities
  7.4.1 Potential Applications
  7.4.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG MANUFACTURERS ANALYSIS

8.1 Applied Genetic Technologies Corp
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.1.4 Business Overview
8.2 Astellas Pharma Inc
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.2.4 Business Overview
8.3 Benitec Biopharma Ltd
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.3.4 Business Overview
8.4 Biokine Therapeutics Ltd
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.4.4 Business Overview
8.5 Crinetics Pharmaceuticals Inc
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.5.4 Business Overview
8.6 Critical Pharmaceuticals Ltd
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.6.4 Business Overview
8.7 Daiichi Sankyo Company Ltd
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.7.4 Business Overview
8.8 Diffusion Pharmaceuticals Inc
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.8.4 Business Overview
8.9 Dong-A Socio Holdings Co Ltd
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2013-2018)
  8.9.4 Business Overview
…

CHAPTER 9 AGE RELATED MACULAR DEGENERATION DRUG MANUFACTURING COST ANALYSIS

9.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Age Related Macular Degeneration Drug Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2016
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG MARKET FORECAST (2018-2023)

13.1 Global Age Related Macular Degeneration Drug Production, Revenue Forecast (2018-2023)
13.2 Global Age Related Macular Degeneration Drug Production, Consumption Forecast by Regions (2018-2023)
13.3 Global Age Related Macular Degeneration Drug Production Forecast by Type (2018-2023)
13.4 Global Age Related Macular Degeneration Drug Consumption Forecast by Application (2018-2023)
13.5 Age Related Macular Degeneration Drug Price Forecast (2018-2023)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Age Related Macular Degeneration Drug
Figure Global Production Market Share of Age Related Macular Degeneration Drug by Eylea016
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Age Related Macular Degeneration Drug Consumption Market Share by Application in 2016
Figure Clinic Examples
Figure Hospital Examples
Figure Others Examples
Figure North America Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2023)
Figure China Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2023)
Figure Japan Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2023)
Figure Southeast Asia Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2023)
Figure India Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Age Related Macular Degeneration Drug Revenue (Million UDS) and Growth Rate (2013-2023)
Table Global Age Related Macular Degeneration Drug Capacity of Key Manufacturers (2016 and 2017)
Table Global Age Related Macular Degeneration Drug Capacity Market Share by Manufacturers (2016 and 2017)
Figure Global Age Related Macular Degeneration Drug Capacity of Key Manufacturers in 2016
Figure Global Age Related Macular Degeneration Drug Capacity of Key Manufacturers in 2017
Table Global Age Related Macular Degeneration Drug Production of Key Manufacturers (2016 and 2017)
Table Global Age Related Macular Degeneration Drug Production Share by Manufacturers (2016 and 2017)
Figure 2015 Age Related Macular Degeneration Drug Production Share by Manufacturers
Figure 2016 Age Related Macular Degeneration Drug Production Share by Manufacturers
Table Global Age Related Macular Degeneration Drug Revenue (Million USD) by Manufacturers (2016 and 2017)
Table Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers (2016 and 2017)
Table 2015 Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers
Table 2016 Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers
Table Global Market Age Related Macular Degeneration Drug Average Price of Key Manufacturers (2016 and 2017)
Figure Global Market Age Related Macular Degeneration Drug Average Price of Key Manufacturers in 2016
Table Manufacturers Age Related Macular Degeneration Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Age Related Macular Degeneration Drug Product Type
Figure Age Related Macular Degeneration Drug Market Share of Top 3 Manufacturers
Figure Age Related Macular Degeneration Drug Market Share of Top 5 Manufacturers
Table Global Age Related Macular Degeneration Drug Capacity by Regions (2013-2018)
Figure Global Age Related Macular Degeneration Drug Capacity Market Share by Regions (2013-2018)
Figure Global Age Related Macular Degeneration Drug Capacity Market Share by Regions (2013-2018)
Figure 2015 Global Age Related Macular Degeneration Drug Capacity Market Share by Regions
Table Global Age Related Macular Degeneration Drug Production by Regions (2013-2018)
Figure Global Age Related Macular Degeneration Drug Production and Market Share by Regions (2013-2018)
Figure Global Age Related Macular Degeneration Drug Production Market Share by Regions (2013-2018)
Figure 2015 Global Age Related Macular Degeneration Drug Production Market Share by Regions
Table Global Age Related Macular Degeneration Drug Revenue by Regions (2013-2018)
Table Global Age Related Macular Degeneration Drug Revenue Market Share by Regions (2013-2018)
Table 2015 Global Age Related Macular Degeneration Drug Revenue Market Share by Regions
Table Global Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table North America Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Europe Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table China Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Japan Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Southeast Asia Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table India Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Global Age Related Macular Degeneration Drug Consumption Market by Regions (2013-2018)
Table Global Age Related Macular Degeneration Drug Consumption Market Share by Regions (2013-2018)
Figure Global Age Related Macular Degeneration Drug Consumption Market Share by Regions (2013-2018)
Figure 2015 Global Age Related Macular Degeneration Drug Consumption Market Share by Regions
Table North America Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2013-2018)
Table Europe Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2013-2018)
Table China Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2013-2018)
Table Japan Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2013-2018)
Table Southeast Asia Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2013-2018)
Table India Age Related Macular Degeneration Drug Production, Consumption, Import & Export (2013-2018)
Table Global Age Related Macular Degeneration Drug Production by Type (2013-2018)
Table Global Age Related Macular Degeneration Drug Production Share by Type (2013-2018)
Figure Production Market Share of Age Related Macular Degeneration Drug by Type (2013-2018)
Figure 2015 Production Market Share of Age Related Macular Degeneration Drug by Type
Table Global Age Related Macular Degeneration Drug Revenue by Type (2013-2018)
Table Global Age Related Macular Degeneration Drug Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Age Related Macular Degeneration Drug by Type (2013-2018)
Figure 2015 Revenue Market Share of Age Related Macular Degeneration Drug by Type
Table Global Age Related Macular Degeneration Drug Price by Type (2013-2018)
Figure Global Age Related Macular Degeneration Drug Production Growth by Type (2013-2018)
Table Global Age Related Macular Degeneration Drug Consumption by Application (2013-2018)
Table Global Age Related Macular Degeneration Drug Consumption Market Share by Application (2013-2018)
Figure Global Age Related Macular Degeneration Drug Consumption Market Share by Application in 2016
Table Global Age Related Macular Degeneration Drug Consumption Growth Rate by Application (2013-2018)
Figure Global Age Related Macular Degeneration Drug Consumption Growth Rate by Application (2013-2018)
Table Applied Genetic Technologies Corp Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Market Share (2013-2018)
Table Astellas Pharma Inc Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Astellas Pharma Inc Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Astellas Pharma Inc Age Related Macular Degeneration Drug Market Share (2013-2018)
Table Benitec Biopharma Ltd Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Benitec Biopharma Ltd Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Benitec Biopharma Ltd Age Related Macular Degeneration Drug Market Share (2013-2018)
Table Biokine Therapeutics Ltd Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Market Share (2013-2018)
Table Crinetics Pharmaceuticals Inc Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Market Share (2013-2018)
Table Critical Pharmaceuticals Ltd Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Market Share (2013-2018)
Table Daiichi Sankyo Company Ltd Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Market Share (2013-2018)
Table Diffusion Pharmaceuticals Inc Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Market Share (2013-2018)
Table Dong-A Socio Holdings Co Ltd Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Production, Revenue, Price and Gross Margin (2013-2018)
Table Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Age Related Macular Degeneration Drug
Figure Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure Age Related Macular Degeneration Drug Industrial Chain Analysis
Table Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2016
Table Major Buyers of Age Related Macular Degeneration Drug
Table Distributors/Traders List
Figure Global Age Related Macular Degeneration Drug Production and Growth Rate Forecast (2018-2023)
Figure Global Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2018-2023)
Table Global Age Related Macular Degeneration Drug Production Forecast by Regions (2018-2023)
Table Global Age Related Macular Degeneration Drug Consumption Forecast by Regions (2018-2023)
Table Global Age Related Macular Degeneration Drug Production Forecast by Type (2018-2023)
Table Global Age Related Macular Degeneration Drug Consumption Forecast by Application (2018-2023)

COMPANIES MENTIONED

Applied Genetic Technologies Corp Astellas Pharma Inc Benitec Biopharma Ltd Biokine Therapeutics Ltd Crinetics Pharmaceuticals Inc Critical Pharmaceuticals Ltd Daiichi Sankyo Company Ltd Diffusion Pharmaceuticals Inc Dong-A Socio Holdings Co Ltd